Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

about

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy In-Hospital Outcomes of Tumor Lysis Syndrome: A Population-Based Study Using the National Inpatient Sample.Febuxostat and tumor lysis syndrome: an indication that remains unclear

P2860

Q28082089-DC78540E-C431-4B10-827C-A8186BC69FC6 Q40042489-3EB663E8-064B-4559-9B05-C64BA8B5F549 Q56967871-CE2CF123-635A-436A-B7B3-AFEABB3E8FAA

P2860

Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

Item

http://www.wikidata.org/entity/Q56968010

description

article

@en

im Februar 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2014

@uk

name

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@en

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@nl

type

Item

label

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@en

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@nl

prefLabel

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@en

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@nl

P1476

Plasma uric acid response to r ...... njury in tumor lysis syndrome?

@en

P2093

Benoit Schlemmer

http://www.w3.org/2001/XMLSchema#string

Catherine Thieblemont

http://www.w3.org/2001/XMLSchema#string

Danielle Reuter

http://www.w3.org/2001/XMLSchema#string

David Schnell

http://www.w3.org/2001/XMLSchema#string

Elie Azoulay

http://www.w3.org/2001/XMLSchema#string

Emmanuel Canet

http://www.w3.org/2001/XMLSchema#string

Etienne Lengline

http://www.w3.org/2001/XMLSchema#string

Lara Zafrani

http://www.w3.org/2001/XMLSchema#string

Lionel Galicier

http://www.w3.org/2001/XMLSchema#string

Morgane Cheminant

http://www.w3.org/2001/XMLSchema#string

P2860

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

The tumor lysis syndrome

Clinical review: specific aspects of acute renal failure in cancer patients

Overview of the Alberta Kidney Disease Network.

Tumour lysis syndrome: new therapeutic strategies and classification.

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.

Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study

Survival in neutropenic patients with severe sepsis or septic shock.

P304

2362-2367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2013.874010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Darmon

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24325633

http://www.w3.org/2001/XMLSchema#string

Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

about

P2860

P2860

Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698